Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization.
| Autor: | Lincoff, A M, Kereiakes, D J, Mascelli, M A, Deckelbaum, L I, Barnathan, E S, Patel, K K, Frederick, B, Nakada, M T, Topol, E J |
|---|---|
| Zdroj: | Circulation; 2001 Jul 10, Vol. 104 Issue 2, p163-167, 5p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|